Biochemical markers evaluation of RAW transformed cells during treatment with various biomaterials.
Upon introduction into the human body, biomaterials initially trigger a foreign-body inflammatory response. Furthermore, the wear debris associated with such materials as those used for orthopedic implants, artificial heart valves, and dental implants can cause the body to mount an inflammatory response. This involves the production of phagocytic macrophages that ingest the foreign material while simultaneously producing cytokines that serve as chemotactic agents for an amplified immune response. Currently titanium (Ti), polyethylene (PE), tricalcium phosphate (TCP) and hydroxyapatite (HA) are widely used as biomaterials in medical implants, and particle size is an important factor in the development of orthopedic, dental, and medical implants. The objective of this study was to investigate the effect of various biomaterials (Ti, mixed particle size polyethylene (MPE), ultra high molecular weight polyethylene (UHMWPE), mixed particle size TCP (MTCP), < 0.38 micron TCP (S-TCP), and hydroxyapatite (HA)) on the inflammatory reactions expressed by transformed RAW macrophages. RAW transformed monocytes were obtained from the American Cell Culture Line, (Rockville, MD). The cells were allowed to incubate in contact with the materials for intervals of 24, 48, and 72 hours. Biochemical tests and morphological evaluations were performed after each time point, including screening for cell number, cell protein levels, supernatant protein levels, lactate dehydrogenase (LDH), Maliondialdehyde (MDA), catalase by following standard lab protocols.
Johnston
W
W
School of Health Related Professions, Department of Orthopaedic Surgery and School of Dentistry, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Carr
S
S
Benghuzzi
H
H
Tucci
M
M
Puckett
A
A
Tsao
A
A
Hughes
J
J
D001672:Biocompatible Materials / Q000494:pharmacology*; D002130:Calcium Phosphates / Q000494:pharmacology; D002374:Catalase / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002461:Cell Line, Transformed; D002516:Ceramics / Q000494:pharmacology; D017886:Durapatite / Q000494:pharmacology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism*; D008315:Malondialdehyde / Q000378:metabolism; D010316:Particle Size; D011095:Polyethylenes / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D014025:Titanium / Q000494:pharmacology
D001672:Biocompatible Materials; D002130:Calcium Phosphates; D011095:Polyethylenes; D011506:Proteins; C485817:beta-tricalcium phosphate; D008315:Malondialdehyde; D017886:Durapatite; D014025:Titanium; D007770:L-Lactate Dehydrogenase; D002374:Catalase; C018392:tricalcium phosphate